Repligen | Omløpsmidler

Current Assets Endring Dato
Agilent USD 4.2B 135M 2024-04
Align Technology USD 2.48B 32.7M 2024-03
Bio Techne USD 610.65M 20.01M 2024-03
BioMarin Pharmaceutical USD 2.99B 28.92M 2024-03
Bristol-Myers Squibb USD 28.67B 1.04B 2024-03
Bruker USD 2.14B 24.6M 2024-03
Catalent USD 2.52B 47M 2024-03
Charles River Laboratories USD 1.67B 59.53M 2024-03
Danaher USD 14.37B 435M 2024-03
Dentsply International USD 1.9B 71M 2024-03
Exact Sciences USD 1.12B 74.1M 2024-03
General Electric USD 59.59B 208M 2024-03
Henry Schein USD 4.08B 410M 2024-03
Illumina USD 2.58B 26M 2024-03
IQVIA Holdings USD 5.65B 55M 2024-03
Mettler Toledo International USD 1.21B 19.09M 2024-03
Myriad Genetics USD 290.3M 23.3M 2024-03
Patterson Companies USD 1.83B 41.89M 2024-01
Pfizer USD 42.42B 31.6B 2024-03
Repligen USD 1.13B 154.56M 2024-03
Revvity USD 3.06B 58.25M 2024-03
Standard Biotools USD 547.56M 389.35M 2024-03
Thermo Fisher Scientific USD 23.64B 949M 2024-03
Waters USD 1.75B 118.34M 2023-12
West Pharmaceutical Services USD 1.69B 279.4M 2024-03



Repligen Omløpsmidler - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Jun 2024.